NCT05979779: Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
- State
- Under way
- Phase
- Phase 2
- People
- 219 taking part
- Started
- 5 Sep 2023
- Primary completion
- 21 Jan 2025
- Arms
- Active Treatment: HU6 Planned doses of HU6
- Results
- None posted
- 7 Aug 2023: Trial registered
- 5 Sep 2023: Trial started